StonvexLoading…
StonvexStonvexStonvexCore line items from OLN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.78B | $6.54B | $6.83B | $9.38B |
Operating Income | $5.30M | $296.50M | $712.10M | $1.78B |
Net Income | $-101.10M | $105.00M | $452.00M | $1.33B |
EPS (Diluted) | $-0.88 | $0.91 | $3.57 | $8.94 |
Total Assets | $7.33B | $7.58B | $7.71B | $8.04B |
Total Liabilities | $5.46B | $5.52B | $5.44B | $5.50B |
Cash & Equivalents | $167.60M | $175.60M | $170.30M | $194.00M |
Free Cash Flow OCF − CapEx | $247.90M | $308.10M | $738.30M | $1.69B |
Shares Outstanding | 113.60M | 115.70M | 120.20M | 132.30M |